Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening

Key facts

Study ID

NCT03482557

Run by

Beth Israel Deaconess Medical Center

People needed

132

Starts

2018-05-17

Expected to finish

2023-08-30

Last updated by the study team

2025-01-09

Who can join

Age: 30 and older, up to 110. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• CESM and MRI exam performed within 3 months of one another.
• CESM and breast MRI exams must be performed as part of imaging work-up based on a screening exam of any type (mammography, tomosynthesis, ultrasound, and MRI)
• CESM studies will include at least four low energy and four recombined images (LCC, LMLO, RCC, RMLO).
• MRI exams will include at least fluid sensitive sequence, multi-phase T1-weighted

You may not qualify if…

• Imaging sets with implants.
• Imaging sets in which a biopsy or surgical intervention was performed since the most recent screening exam, prior to acquisition of the study MRI or CESM.
• Imaging sets in which a biopsy was recommended, but biopsy was not performed and 2 year imaging follow-up is not available

Where it is running

• Beth Israel Deaconess — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.